Regulonix is an early-stage biotechnology company developing non-opioid drugs for chronic pain. By indirectly targeting the sodium channel NaV1.7 – a well-established and genetically validated pain target – and focusing on the signaling pathways that control this channel’s activity, the Regulonix team has isolated compounds demonstrated in animal models to be non-addictive and more effective than morphine. 

Biotechnology

Regulonix Holding

Regulonix Holding's headquarters in Tucson, AZ, United States

Rajesh Khanna

Frank Porreca

Amol Patwardhan

Kathleen Rodgers

Gerald Zamponi

Regulonix Holding's Leadership Team includes Rajesh Khanna.

About

People (1)

Rajesh Khanna

Jobs